Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hologic Inc (NQ: HOLX )

75.02 +0.07 (+0.09%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,451,370
Open 75.03
Bid (Size) 74.15 (5)
Ask (Size) 77.49 (1)
Prev. Close 74.95
Today's Range 74.12 - 75.28
52wk Range 64.02 - 82.45
Shares Outstanding 253,487,389
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Deep Dive Into Hologic Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
HOLX Stock Earnings: Hologic Beats EPS, Beats Revenue for Q2 2024
HOLX stock results show that Hologic beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
+3.53%
+3.53%
1 Month
+0.13%
+0.13%
3 Month
+1.67%
+1.67%
6 Month
+4.38%
+4.38%
1 Year
-7.45%
-7.45%

More News

Read More
Hologic Announces Financial Results for Second Quarter of Fiscal 2024
From Hologic, Inc.
Via Business Wire
Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company
From Hologic, Inc.
Via Business Wire
The Analyst Landscape: 4 Takes On Hologic
Via Benzinga
Good technical signals and a possible breakout for HOLOGIC INC.
Via Chartmill
Analyst Ratings For Hologic
Via Benzinga
Biotech Innovations Paving the Way in Breast Cancer Fight
Via FinancialNewsMedia
Topics Death
Exposures Death Product Safety
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
From Hologic, Inc.
Via Business Wire
Based on good technical signals, HOLOGIC INC is potentially setting up for a breakout.
Via Chartmill
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
Via Talk Markets
Recap: Hologic Q1 Earnings
Via Benzinga
Earnings Outlook For Hologic
Via Benzinga
Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
From Hologic, Inc.
Via Business Wire
Hologic to Unveil Groundbreaking AI Research at ECR 2024
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentations at Upcoming Investor Conferences
From Hologic, Inc.
Via Business Wire
First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
Via Benzinga
7 Mutual Funds That Will Outperform in Any Market
Via InvestorPlace
Amazon To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
From Hologic, Inc.
Via Business Wire
Hologic Reports Better-Than-Expected Q1 Results
Via Benzinga
Hologic Announces Financial Results for First Quarter of Fiscal 2024
From Hologic, Inc.
Via Business Wire
7 Mighty Healthcare Stocks Changing the Game of Medicine
Via InvestorPlace
Time to buy these 3 healthcare companies that raised revenue guidance?
Via MarketBeat
Earnings Scheduled For February 1, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.